5h agoStocktwits NewsBULLISH 73General
Why Did AMD, WBD, MRNA Stocks Surge To 52-Week Highs Today?
Advanced Micro Devices, Warner Bros. Discovery and Moderna stocks surged to annual highs amid a series of positive catalysts.
Archived explainer. For the current picture see today's MRNA page.
Why Is MODERNA INC (MRNA) Stock Up Today?
By the Top Tier Newswire AI Desk · September 22, 2026 at 12:06 AM ET · reviewed against 14 wire stories
MODERNA INC (MRNA) is up +12.27% in the latest session. Our newswire has captured 14 stories on MRNA across 12 sources in the last 36 hours, with AI sentiment reading bullish (avg 65/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Moderna Inc (MRNA) surged 12.27% to $172.94 on September 21, setting a new 52-week high. The stock’s sharp rise followed the announcement that the company will present late-breaking Phase 3 melanoma data for its intismeran autogene plus pembrolizumab therapy at the ESMO 2026 oncology congress on October 24. The data is expected to provide further insight into the effectiveness of Moderna’s personalized cancer vaccine, which has generated growing investor and medical interest.
The stock’s rally was fueled by expectations that the upcoming data could validate the treatment’s potential in melanoma and possibly other cancers such as pancreatic and lung. Moderna also plans to present additional trial updates at the ESMO event. The company has not yet released full results but has emphasized the significance of the data in shaping the future of its oncology portfolio. The stock’s recent performance reflects strong market optimism, with the price now 71% above the average Wall Street price target. Over the past 30 days, investor sentiment has improved, with the average score rising from 57 to 61 out of 100.
What The Data Shows
The stock has gained 18.8% over the last eight sessions, moving from $135.66 to $161.14. Unusual options activity has also supported the move, with $35.4 million in call premium exchanged versus $2.2 million in put premium. The largest single print in the last 36 hours totaled $15.7 million. On September 21, the stock printed one fresh 52-week low and 30 fresh 52-week highs. Insider sales have continued recently, with five transactions totaling $49.2 million in the last 90 days.
What To Watch
The October 24 ESMO presentation will be a key event to monitor. The data could influence investor sentiment and potentially impact the stock’s trajectory in the coming weeks.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
MRNA by the numbers
Last: $172.94Session: +12.27%7 sessions: +18.78%Coverage: 14 stories / 12 sourcesAI sentiment: 65/100 (bullish)Mkt cap: $61.5B52w: $22.28 to $176.66
The headlines behind the move
11h agoSeeking AlphaBULLISH 55General
Stocks to watch on Monday after hours: MRNA, ARM, and PBF
Wall Street’s major averages closed firmly in the green Monday as investors awaited the upcoming Trump-Xi summit.
12h agoSeeking AlphaBULLISH 73Product/PR
Moderna rallies 12% to set new high
Moderna (MRNA) hits a new 52-week high on ESMO 2026 oncology data plans as intismeran buzz grows.
12h agoTechStock²BULLISH 73Earnings
Moderna Stock’s 13% Rally Sets a $70 Billion Test for October Cancer Data
New York, September 21, 2026, 15:54 (EDT) Moderna rose 13.00% to $174.06 and touched a 52-week high.Full Phase 3 melanoma data are scheduled for October 24.The stock trades 71% above Wall Street's average price target. Moderna, Inc. (NASDAQ:MRNA) climbed 13.00% to $174.06 on Monday afternoon, touching a 52-week high of $176.86. A newly dated cancer-vaccine…
13h agoMarketWatchBULLISH 56Product/PR
Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.
One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.
13h agoTipRanksBULLISH 73Product/PR
Why Is Moderna Stock (MRNA) Soaring Today, September 21?
Moderna shares ($MRNA) surged by more than 14% to about $176 on Monday afternoon. This came after the U.S. pharma and biotech firm announced a key update in a state...
15h agoStocktwits NewsBULLISH 64Product/PR
Moderna To Present Additional Data From Key Melanoma Trial At ESMO Congress – Retail Says ‘Breakout Is Getting Hard To Ignore’
Moderna will showcase detailed melanoma results for Intismeran at ESMO, alongside data and trial updates exploring the personalized therapy in pancreatic and lung cancers.
15h agoBarron'sBULLISH 67Product/PR
Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on MRNA: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier MRNA move explainers: 2026-09-22 · 2026-09-21 · 2026-09-11 · 2026-09-02 · 2026-09-01 · 2026-08-27 · 2026-08-26 · 2026-08-25 · 2026-08-24 · 2026-08-21 · 2026-08-20 · 2026-08-19 · 2026-07-11